Vaccines manufacturing

The BIA’s manufacturing community has been at the heart of efforts to understand the challenges of the manufacturing and scale up of a successful COVID-19 vaccine. Industry and academics from all corners of the UK have contributed their expertise and resources, to find solutions to this monumental challenge by supporting both the Oxford University Jenner Institute’s ChAdOX and Imperial’s RNA vaccine. The ChAdOx vaccine (now AZD1222) was co-invented by the University of Oxford and its spin-out company, Vaccitech.

As these projects moved from advice to multi-million-pound contracts, there was a natural stepping-off point for the BIA from the point-of-delivery co-ordination. That moment arrived in July, where we handed over the delivery baton to the UK Government’s Vaccines Taskforce.

The experts and capacity organised via our initial Taskforce continue to deliver their vaccines work directly to the Government. The BIA has retained a strategic advisory function ready to help but is not responsible for overseeing the programme management of what has become a series of key UK State deliverables.

Please follow the button below for more details on the work of the BIA COVID-19 Vaccine Manufacturing Taskforce. 

1 of 4

2 of 4

3 of 4

4 of 4

For more information about the vaccines manufacturing taskforce or to get involved please contact [email protected]